Search Results Search Sort by RelevanceMost Recent Viewpoint Aug 2007 Practicing Evidence-Based and Culturally Competent Medicine: Is it Possible? Commentary 2 Matthew Wynia, MD, MPH and Megan Johnson Despite the possible conflict between evidence-based and cultural competence approaches to medical care, both embody the ideals of medical ethics. Virtual Mentor. 2007;9(8):574-578. doi: 10.1001/virtualmentor.2007.9.8.oped1-0708. Viewpoint Aug 2007 Practicing Evidence-Based and Culturally Competent Medicine: Is it Possible? Commentary 1 Romana Hasnain-Wynia, PhD and Debra Pierce Despite the possible conflict between evidence-based and cultural competence approaches to medical care, both embody the ideals of medical ethics. Virtual Mentor. 2007;9(8):572-574. doi: 10.1001/virtualmentor.2007.9.8.oped1-0708. State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701. Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH A physician argues that cost should not be a major consideration in a hospital's decision to provide palliative care services to patients. Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520. Viewpoint Jul 2024 Opioid Epidemic Grief and Characterological Harm Reduction Christy A. Rentmeester, PhD Becoming callous, bitter, or resentful are harms we can suffer when grieving losses, especially at epidemic scale. AMA J Ethics. 2024;26(7):E587-590. doi: 10.1001/amajethics.2024.587. Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546. Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Page 28 Page 29 … Next page Next › Last page Last »
Viewpoint Aug 2007 Practicing Evidence-Based and Culturally Competent Medicine: Is it Possible? Commentary 2 Matthew Wynia, MD, MPH and Megan Johnson Despite the possible conflict between evidence-based and cultural competence approaches to medical care, both embody the ideals of medical ethics. Virtual Mentor. 2007;9(8):574-578. doi: 10.1001/virtualmentor.2007.9.8.oped1-0708.
Viewpoint Aug 2007 Practicing Evidence-Based and Culturally Competent Medicine: Is it Possible? Commentary 1 Romana Hasnain-Wynia, PhD and Debra Pierce Despite the possible conflict between evidence-based and cultural competence approaches to medical care, both embody the ideals of medical ethics. Virtual Mentor. 2007;9(8):572-574. doi: 10.1001/virtualmentor.2007.9.8.oped1-0708.
State of the Art and Science Jan 2007 Development of the Human Papillomavirus Vaccine and Guidelines for Its Use Amy L. Jonson, MD A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007;9(1):30-33. doi: 10.1001/virtualmentor.2007.9.1.cprl1-0701.
Policy Forum Sep 2006 Should Cost Be a Consideration in Palliative Care? Maria J. Silveira, MD, MA, MPH A physician argues that cost should not be a major consideration in a hospital's decision to provide palliative care services to patients. Virtual Mentor. 2006;8(9):599-601. doi: 10.1001/virtualmentor.2006.8.9.pfor1-0609.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
Viewpoint Jul 2024 Opioid Epidemic Grief and Characterological Harm Reduction Christy A. Rentmeester, PhD Becoming callous, bitter, or resentful are harms we can suffer when grieving losses, especially at epidemic scale. AMA J Ethics. 2024;26(7):E587-590. doi: 10.1001/amajethics.2024.587.
Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546.